Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
1.7K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.7K
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-orchestrated design-build-test-learn is the future of mammalian biodesign.

Nature biomedical engineering·2026
Same author

A synthetic angiotensin II/ACE2-based hormone shunt controlling experimental hypertension.

Nature communications·2026
Same author

Traceless Regulation of Genetic Circuitry.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Remote-controlled genetics: A new frontier in precision therapy.

Clinical and translational medicine·2025
Same author

Regulation of therapeutic protein release in response to circadian biomarkers.

Nature communications·2025
Same author

Synthetic closed-loop gene circuit for phenylalanine regulation.

Nucleic acids research·2025
Same journal

Genetic analysis of imaging-derived phenotypes.

Nature reviews. Genetics·2026
Same journal

Genetic origins and constraints of evolutionary innovation.

Nature reviews. Genetics·2026
Same journal

Single-cell four-omics with CHARM.

Nature reviews. Genetics·2026
Same journal

Molecular integration of seasonal temperature signals in flowering time control.

Nature reviews. Genetics·2026
Same journal

RBPscan measures protein-RNA interactions in living cells.

Nature reviews. Genetics·2026
Same journal

Revisiting retinal and macular degeneration in the genomics era.

Nature reviews. Genetics·2026
See all related articles

Related Experiment Video

Updated: Mar 13, 2026

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.9K

Next-generation programmable cell therapies for precision medicine.

Ana Palma Teixeira1, Dominique Aubel2, Martin Fussenegger3,4

  • 1Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.

Nature Reviews. Genetics
|March 12, 2026
PubMed
Summary
This summary is machine-generated.

Engineered cell therapies are advancing precision medicine. These living therapeutics use synthetic gene circuits for targeted treatments, with new delivery methods improving accessibility and in vivo reprogramming.

More Related Videos

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices
09:30

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices

Published on: December 5, 2025

612
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

1.0K

Related Experiment Videos

Last Updated: Mar 13, 2026

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.9K
Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices
09:30

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices

Published on: December 5, 2025

612
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

1.0K

Area of Science:

  • Biotechnology
  • Cellular Engineering
  • Synthetic Biology

Background:

  • Engineered cell therapies, like CAR-T cells, show promise in precision medicine.
  • Next-generation platforms utilize diverse cells (immune, stem) for broader disease applications.
  • Current ex vivo engineering faces scalability, cost, and accessibility challenges.

Purpose of the Study:

  • To review emerging strategies for engineering human cells with therapeutic functions.
  • To highlight advancements in synthetic gene circuits and delivery systems.
  • To discuss challenges and future directions in cell therapy development.

Main Methods:

  • Harnessing synthetic gene circuits for targeted cytotoxicity and effector protein modulation.
  • Developing allogeneic cell products and in vivo reprogramming techniques.
  • Utilizing advanced targeted delivery systems (viral vectors, nanoparticles, virus-like particles).

Main Results:

  • Engineered cells can act in real-time, responding to disease cues.
  • Synthetic gene circuits enable context-responsive therapeutic functions.
  • New delivery methods expand the potential for in vivo cell programming.

Conclusions:

  • Engineered cell therapies represent a significant advance in precision medicine.
  • Modular control systems and delivery innovations are key to future success.
  • Overcoming translational hurdles is crucial for widespread clinical adoption.